Gain Therapeutics Inc. (GANX)
NASDAQ · Healthcare
Gain Therapeutics Inc. EPS 2020–2023
Gain Therapeutics Inc. annual/quarterly eps history and growth rate from 2020 to 2023. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Gain Therapeutics Inc. eps for the quarter ending March 31, 2023 was $0.43, a 53.57% increase year-over-year.
- Gain Therapeutics Inc. annual eps for 2023 was $1.71, a 15.54% increase from 2022.
- Gain Therapeutics Inc. annual eps for 2022 was $1.48, a 8.03% increase from 2021.
- Gain Therapeutics Inc. annual eps for 2021 was $1.37, a 3.01% increase from 2020.
- Gain Therapeutics Inc. annual eps for 2020 was $1.33.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Gain Therapeutics Inc. EPS — FAQ
Gain Therapeutics Inc. (GANX) eps over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Gain Therapeutics Inc.'s eps?
Gain Therapeutics Inc. (GANX) reported eps of $-1.71 for fiscal 2023.
Where can I see GANX's eps history?
The chart and table above show Gain Therapeutics Inc.'s eps by year and by quarter, including the growth rate.